Boehringer Ingelheim Venture Fund — Full Portfolio
21 tracked investments · listed companies and verified rows first
Acousia Therapeutics develops small-molecule drug candidates with a dual mode of action for treating acute and chronic sensorineural hearing loss (SNHL), targeting outer hair cells in the inner ear to preserve and enhance natural hearing.
BiotechDigital HealthHealthtechMedical DevicesTübingen, DE
Hubert Löwenheim(Founder / Board Member)
Co-investorsKfWCreathor VenturesLBBW Venture Capital GmbHEsperante Ventures
ArrePath is a biotechnology company that applies AI/ML to drug discovery and development.
AI & Machine LearningBiotechDeep Tech
Zemer Gitai(Founder and SAB Chair)Kevin Krause(President and Chief Executive Officer)
Co-investorsInnospark VenturesInsight Partners
DiogenX is a preclinical-stage biotech company developing biologic therapeutics aimed at restoring insulin-producing beta cells for people with Type 1 diabetes.
BiotechDeep TechDigital HealthHealthtechMarseille, FR
Benjamin Charles(Co-Founder & CEO)inPatrick Collombat(Co-Founder & Scientific Advisor)inJean-Pascal Tranié(Co-Founder)in
Co-investorsAdBio partnersRoche Venture FundSunstone CapitalJDRF T1D Fund
Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.
BiotechDigital HealthHealthtechMedical DevicesSingapore, SG
Brian Burke(Co-Founder and Advisor)inMark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)inMonica Shah(Chief Medical Officer)inAl Gianchetti(Chief Executive Officer)in
Co-investorsAngelini VenturesKurma PartnersClavystBioHighlight CapitalSEEDS Capital
Obulytix develops Precision Lysin Therapeutics, a novel class of engineered biologics designed to target multidrug-resistant Gram-negative bacteria for severe bloodstream and lung infections.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesGhent, BE
Yves Briers(Scientific Founder)in
Co-investorsQbic Fund
Rewind Therapeutics is a biotech company focused on neurodegeneration and neuroimmune diseases, with leadership and scientific advisory expertise in drug discovery, clinical development, and translational research for conditions like multiple sclerosis and Alzheimer's disease.
BiotechDeep TechDigital HealthHealthtechMedical DevicesLeuven, BE
Jim Van Heusden(Executive Chair)Irene Knuesel(Chief Scientific Officer)Christophe Van Vaeck(Chief Financial Officer)Ricardo Hermosilla(Head of Translational Medicine)Stephen Burbidge(VP Preclinical Drug Development)
Co-investorsPMVM VenturesSunstone Capital
Tacalyx develops novel anticancer therapeutics that target Tumor-Associated Carbohydrate Antigens (TACAs), including antibody-drug conjugate programs.
BiotechDeep TechMedical DevicesBerlin, DE
Peter Seeberger(Co-founder (Prof. Dr.))Oren Moscovitz(CSO & Co-founder)
Co-investorsCreathor VenturesKurma PartnerscoparionThuja CapitalApollo Health Ventures
Topas Therapeutics develops nanoparticle-based therapies to induce immune tolerance for autoimmune and immune-mediated diseases.
BiotechHealthtech
Hugo Fry(Chief Executive Officer)inChristian Schröter(Chief Operating Officer)Cristina de Min(Chief Medical Officer)Anne Burger(Chief Financial Officer)Alex Marshall(Chief Business Officer)in
Co-investorsEMBL VenturesGimvBioMedPartnersEpidarex Capital
Abalos Therapeutics develops immunotherapy treatments using arenavirus-based approaches for cancer.
BiotechHealthtech
Co-investorsVentura BioMed InvestorsApollo Health Ventures
Asgard provides sales intelligence and intent detection data to B2B companies, identifying qualified prospects and their specific needs for targeted sales outreach and account-based marketing campaigns.
AI & Machine LearningData & InfrastructureEnterprise SoftwareSales TechParis, FR
Co-investorsTechstarsIndustrifondenNovo HoldingsRobot Ventures
Asgard Therapeutics develops direct cell reprogramming technologies that convert cancer cells into dendritic cells to restore anti-cancer immune responses.
AI & Machine LearningBiotechHealthtechMedical DevicesLund, SE
Cristiana Pires(Co-founder and CEO)inFábio Rosa(Co-founder and VP of Research)inFilipe Pereira(Co-founder and Head of Innovation)in
Co-investorsIndustrifondenLU InnovationNovo Holdings
C-mo develops an automated wearable device that records and analyzes cough patterns in real-time for continuous patient monitoring.
Digital HealthHealthtechMedical DevicesCaparica, PT
Co-investorsNovalis BiotechPortugal Ventures
Centauri Therapeutics develops the Alphamer platform, a proprietary antibody recruiting molecule technology designed to redirect the immune system against disease targets.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsAMR Action FundNCL Technology Ventures Ltd.
Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy.
BiotechDigital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)inDavid Klein(Executive Officer, Director)inRandall Stanicky(Executive Officer)in
BoardAlex Zisson(Director)Lee Shapiro(Director)inCris De Luca(Director)in
Co-investorsAccelmed PartnersH.I.G. CapitalH.I.G. HealthBridge PartnersHealth Catalyst CapitalHikma VenturesSanofi Ventures+4 more
Delonix Group operates multiple hotel and experiential consumption brands across Asia-Pacific, leveraging AI and digital technology to drive member growth and innovation in hospitality.
ConsumerShenzhen, CN
郑南雁
Co-investorsINCE CapitalIDG CapitalZhenFund
Etherna is an RNA-LNP technology company that develops proprietary RNA chemistry and lipid nanoparticle delivery platforms for nucleic acid–based therapeutics, and partners with pharma and biotech organizations from early discovery through clinical development.
BiotechDeep TechMedical DevicesNiel, BE
Co-investorsFund+PMVEQT Life SciencesNovalis LifeSciencesPWV
BiotechPhoenix, US
Douglas Grant McFadden, Ph.D.(Director)Steven J. Potts, Ph.D.(President and Chief Executive Officer)Ting Xiao(Director)Jason Rushton(Director)Kanad Das, Ph.D.(Director)Michael G. Wood(Executive Officer)
Co-investorsB Capital GroupCity Hill VenturesDelos CapitalKorea Investment PartnersLumira VenturesLYZZ Capital+1 more
.jpeg){kind=logo}
Optina develops a retinal imaging and AI platform for diagnosing and managing Age-Related Macular Degeneration in eye care specialists and patients.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsDigitalDx VenturesDesjardins CapitalHike VenturesZoic Capital
Refoxy is a science-driven company focused on drug discovery, medicinal chemistry, and bioinformatics.
BiotechDeep TechHealthtechLongevity
Victor Bustos(Co-Founder & CEO)inWolfgang Link(Scientific Co-founder & Advisor)inAndrew Pierce(Chief Science Officer)in
Co-investorsKorify CapitalApollo Health VenturesHTGF
Rgenta develops orally available small molecule therapies that target RNA to address diseases previously considered undruggable, with programs in oncology (targeting proteins such as MYB in solid tumors and hematologic cancers) and central nervous system repeat expansion disorders like Huntington's disease.
AI & Machine LearningBiotechDeep TechHealthtechCambridge, US
Travis Wager(Co-founder, President and CSO)inHualin Simon Xi(Executive Officer, Director)Zhiping Weng(Co-founder)inSimon Xi(Co-founder and CEO)inJackie Walling(CMO)Debasish Roychowdhury(Director)
Co-investorsDelos CapitalVivo CapitalAMR Action FundKorea Investment PartnersLilly Asia VenturesMatrix Capital Management+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.